APP and Alzheimer disease: Then, we assessed the cognitive levels of APP/PS1 mice overexpressing SV2A to further explore the effect of SV2A on cognitive ability in AD, and the results showed that SV2A upregulation could significantly improve the cognitive function of AD model mice (Figure S3).